Infusion bag of midazolam for intravenous use
US11246801B2 · kind B2 · utility
0Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2020 |
| Grant date | Feb 15, 2022 |
| Priority date | — |
| Expiry date | May 4, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M5/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an infusion container comprising a sterile, ready-to-use, stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof, suitable for direct intravenous infusion to a patient in need thereof. The invention also relates to a novel infusion container having plurality of ports that is suitable for delivering or receiving a sterile fluid, such as the said stable aqueous solution of Midazolam or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.